2012 EDUCATIONAL BOOK - American Society of Clinical Oncology

LUNG CANCER SCREENING
19. Montes RP. The cost of CT screening: year gained via lung cancer
screening could cost $38,000. The Cancer Letter. 2011;37:15-16.
20. CT Technique Chart. National Lung Screening Trial-American College
of Radiology Imaging Network Protocol 6654. http://www.acrin.org/Default.
aspx?tabid�282. Accessed February 19, 2011.
21. Daqing M, Linning E. Volumetric measurement pulmonary groundglass
opacity nodules with multi-detector CT: Effect of various tube current
on measurement accuracy—a chest CT phantom study. AJR. 2009;16:934-
939.
22. Park CM, Goo JM, Lee HJ, et al. Persistent pure ground-glass nodules
in the lung: Interscan variability of semiautomated volume and attenuation
measurements. AJR. 2010;195:W408-414.
23. Van Klaveren RJ, Oudkerk M, Prokop M, et al. Management of
lung nodules detected by volume CT scanning. N Engl J Med. 2009;361:2221-
2229.
24. MacMahon H, Austin JHM, Gamsu G, et al. Guidelines for management
of small pulmonary nodules detected on CT scans: a statement from the
Fleischner Society. Radiol. 2005;237:395-400.
25. Raupach T, Merker J, Hasenfuss G, et al. Knowledge gaps about
smoking cessation in hospitalized patients and their doctors. Eur J Cardiovasc
Prev Rehabil. 2011;18:334-341.
26. Tong EK, Strouse R, Hall J, et al.. National survey of US health
professionals’ smoking prevalence, cessation practices, and beliefs. Nicotine
Tobac Res. 2010;12:724-733.
27. Stuber J, Galea S, Link BG. Smoking and the emergence of a stigmatized
social status. Soc Science Med. 2008;67:420-430.
28. Niederdeppe J, Levy AG. Fatalistic beliefs about cancer prevention and
three prevention behaviors. Cancer Epidemiol Biomarkers Prev. 2007;16:998-
1003.
29. Wood DE, Eapen GA, Ettinger DS, et al. Lung cancer screening. J Natl
Compr Canc Netw. 2012;10:24-65.
30. International Early Lung Cancer Action Program: Enrollment and
Screening Protocol. http://www.ielcap.org/professionals/docs/ielcap.pdf. Accessed
March 27, 2012.
31. Godoy MC, Naidich DP. Subsolid pulmonary nodules and the spectrum
of peripheral adenocarcinomas of the lung: Recommended interim guidelines
for assessment and management. Radiology. 2009;253:606-622.
32. Eisenberg RL, Bankier AA, Boiselle PM. Compliance with Fleischner
Society guidelines for management of small lung nodules: A survey of 834
radiologists. Radiology. 2010;255:218-224.
33. Esmaili A, Munden RF, Mohammed TLH. Small pulmonary nodule
management: A survey of the members of the Society of Thoracic Radiology
with comparison to the Fleischner Society guidelines. J Thorac Imaging.
2011;26:27-31.
34. Ettinger DS, Akerley W, Bepler G, et al. Non-small cell lung cancer.
J Natl Compr Canc Netw. 2010;8:740-801.
35. Wood DE, Farjah F. Surgeon Specialty is Associated with Better
Outcomes: The Facts Speak for Themselves. Ann Thorac Surg. 2009;88:1393-
1395.
36. Farjah F, Flum DR, Varghese TK, et al. Surgeon specialty and longterm
survival following resection for lung cancer. Ann Thorac Surg. 2009;87:
995-1006.
37. Travis WD, Brambilla E, Noguchi M, et al. International Association
for the Study of Lung Cancer/American Thoracic Society/European Respiratory
Society international multidisciplinary classification of lung adenocarcinoma.
J Thorac Oncol. 2011;6:244-285.
38. Iwano S, Nakamura T, Kamioka Y, et al. Computer-aided differentiation
of malignant from benign solitary pulmonary nodules imaged by highresolution
CT. Comput Med Imag Graph. 2008;32:416-422.
39. Way TW, Sahiner B, Chan H-P, et al. Computer-aided diagnosis of
pulmonary nodules on CT scans: Improvement of classification performance
with nodule surface features. Med Phys. 2009;36:3086-3098.
40. Lokke A, Lang P, Scharling H, et al. Developing COPD: A 25-year
follow up study of the general population. Thorax. 2006;61:935-939.
41. Young RP, Hopkins RJ, Christmas T, et al. COPD prevalence is
increased in lung cancer, independent of age, sex, and smoking history. Eur
Respir J. 2009;34:380-386.
42. Adcock IM, Caramori G, Barnes PJ. Choric obstructive pulmonary disease
and lung cancer: New molecular insights. Respiration. 2011;81:265-284.
43. Young RP, Hopkins RJ, Whittington CF, et al. Individual and cumulative
effects of GWAS susceptibility loci in lung cancer: Associations after
sub-phenotyping for COPD. PLos ONE. 2011;6:e16476.
44. Hasegawa M, Nasuhara Y, Onodera Y, et al. Airflow limitations and
airway dimensions in chronic obstructive pulmonary disease. Am J Respir
Crit Care Med. 2006;173:1309-1315.
45. Punturieri A, Szabo E, Croxton T, et al. Lung cancer and chronic
obstructive pulmonary disease: Needs and opportunities for integrated research.
J Natl Cancer Inst. 2009;101:554-559.
46. Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumor-derived
exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol. 2008;
110:13-21.
47. Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as
stable blood-based markers for cancer detection. Proc Natl Acad Sci USA.
2008;105:10513-10518.
48. Palmisano WA, Divine KK, Saccomanno G, et al. Predicting lung cancer
by detecting aberrant promoter methylation in sputum. Cancer Res. 2000;60:
5954-5958.
49. NLST-ACRIN Biorepository. http://www.acrin.org/RESEARCHERS/
POLICIES/NLSTACRINBIOREPOSITORY.aspx. Accessed March 28, 2012.
457